Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

Kentaro Hayashida, Thierry Lefèvre

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

Significant aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) has been shown to be associated with worse mid-term outcome. The two-year follow-up results of the PARTNER US trial showed that not only ≥3/4 AR grade, but also grade 2 had a significant impact on mortality. Thus, prevention and treatment of significant AR after TAVI is of great importance. Usually, AR after TAVI consists mostly of paravalvular leak and significant central AR is uncommon. Here we describe measures to decrease the risk of AR after TAVI which are currently available.

Original languageEnglish
Pages (from-to)Q34-Q40
JournalEuroIntervention
Volume8
DOIs
Publication statusPublished - 2012 Jan 1

Keywords

  • Aortic regurgitation
  • TAVI

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Access to Document

Fingerprint Dive into the research topics of 'Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation'. Together they form a unique fingerprint.

Cite this